Palantir Stock Is Interesting, but Here's What I'd Buy Instead

Palantir's AI Platform (AIP) has driven a sharp revenue acceleration — revenue was up 70% year-over-year last quarter and marked the tenth consecutive quarter of accelerating growth after only 13% growth in Q2 2023 — while its largest customer, the U.S. government, has expanded usage. Despite strong operational momentum, the stock trades at a rich forward price-to-sales multiple of about 45x (based on 2026 analyst estimates). By contrast, UiPath, with its Maestro orchestration platform for AI agents (building on its RPA franchise), trades at a much lower forward P/S of roughly 3.7 and is presented as a cheaper way to play agentic AI adoption with potential upside if sales reaccelerate.

Analysis

Market structure: Maestro-style orchestration (UiPath PATH) and AIP-style OS (Palantir PLTR) are direct beneficiaries as enterprises shift from point AI tools to agent/bot management layers; NVDA remains the primary hardware beneficiary. Winners: PATH, PLTR, NVDA; losers: pure-play system integrators and legacy on-prem vendors lacking agent governance. The market is bifurcated—PATH trades at ~3.7x forward P/S vs PLTR ~45x—signaling demand for growth stories but also a crowded, high-premium end where share reallocation can be abrupt.

Risk assessment: Tail risks include regulatory constraints (EU AI Act / US procurement rules) within 6–18 months, a material cut in U.S. government contracting (PLTR revenue concentration risk), or a sharp GPU supply shock that raises compute costs 20–50%. Immediate moves (days) will be sentiment-driven around earnings; 3–6 months for contract wins/losses to show; 12–36 months for durable platform adoption and margin expansion. Hidden dependencies: reliance on NVDA GPUs, cloud-cost sensitivity, and customer concentration (DoD/large enterprises) which magnify second-order cashflow risk.

Trade implications: Direct play: allocate to PATH exposure (see decisions) while hedging PLTR valuation risk. Pair trades (long PATH, short PLTR) exploit relative mispricing if PATH accelerates to 30–60% YoY growth; use options to cap downside and monetize elevated IV in PLTR. Rotate sector exposure into AI infra (NVDA) and software orchestration; trim legacy consulting positions by 20–40% over next 3 months.

Contrarian angles: Consensus underestimates the durability of low-cost bots—RPA + orchestration can persist, meaning PATH’s current multiple gap to PLTR may compress higher if PATH shows 40%+ YoY revenue acceleration. Conversely, PLTR’s premium is fragile: a single large contract non-renewal or conservative FY guide could trigger 30–50% multiple compression. Historical parallel: Palantir’s own re-rating shows rapid upside but also rapid downside when expectations diverge from contract visibility.

Key Decisions for Investors

• Establish a 2–3% net long position in UiPath (PATH) via shares or buy 18–24 month LEAP calls (delta ~0.6) within 30–60 days; target 2x–3x return over 12–24 months if PATH achieves >35–40% YoY revenue acceleration, cut to flat if trailing two quarters show <20% YoY growth.
• Initiate a 0.75–1.5% tactical short/hedge on Palantir (PLTR) via borrowed shares or buy 9–12 month puts 5–15% OTM to protect portfolio convexity; take profits if PLTR falls 25% or if forward P/S compresses toward 20x, unwind if PLTR posts consecutive quarters of >50% YoY revenue growth and margin expansion.
• Implement a pair trade: long PATH 2% vs short PLTR 1.25% dollar-neutral (adjust notional for beta), time horizon 6–18 months; take profit when PATH/PLTR relative performance improves by 40% or after 18 months.
• Overweight semiconductor/AI infra (NVDA) by 1–2% and underweight legacy systems-integration/consulting by 20–40% of current allocation over the next 3 months to capture infrastructure spending tailwinds.
• Monitor regulatory and procurement catalysts over the next 60–90 days: if EU AI Act or US DoD guidance imposes stricter on-prem/agent controls or if a top-3 PLTR customer delays renewals, reduce PATH exposure by 50% and cover PLTR short within 10 trading days.